BlueWillow Biologics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Ann Arbor MI United States (1999)

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

BlueWillow Biologics | Okati Research Center, LLC